Clinical Trials Browser

Recruiting × OTHER × Breast Neoplasms × Clear all

NCT04003038 2026-04-16

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Phase NA Recruiting

Breast Neoplasms, Obesity

NCT05056818 2026-04-16

Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics

Breast Neoplasms

NCT05534438 2026-04-16

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT06545682 2026-04-16

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

Phase 1 Recruiting

BreastDermatologic

Breast Neoplasms, Melanoma

NCT06681064 2026-04-16

BELIEVE

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06964802 2026-04-16

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

Phase NA Recruiting

Breast Neoplasms

NCT07447414 2026-04-16

LUBRECA

Phase NA Recruiting

Breast Neoplasms

NCT07467824 2026-04-16

PREACT

Phase NA Recruiting

Breast Neoplasms, Motor Activity

NCT03604315 2026-04-15

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Phase 1 Recruiting

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04852887 2026-04-15

DEBRA

Phase 3 Recruiting

Breast Neoplasms

NCT05042687 2026-04-15

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT05394259 2026-04-15

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

Phase 1 Recruiting

BreastGastrointestinal

Breast Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT07076485 2026-04-15

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT07198581 2026-04-15

ALLIANCE

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07531836 2026-04-15

PREHAB-BC65

Phase NA Recruiting

Frailty, Breast Neoplasms, Sarcopenia

NCT07532434 2026-04-15

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT07400523 2026-04-14

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Recruiting

Breast Neoplasms

NCT04342546 2026-04-13

PRETORIA

Phase NA Recruiting

Breast Neoplasms

NCT04768426 2026-04-13

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Phase 2 Recruiting

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT05030038 2026-04-13

Oral Aromatase Inhibitors Modify the Gut Microbiome

Breast Neoplasms

NCT05095207 2026-04-13

Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT05313191 2026-04-13

ReRT

Phase NA Recruiting

BreastCNSGastrointestinalGenitourinaryHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neoplasms, Prostatic Neoplasms, Central Nervous System Neoplasms

NCT05837455 2026-04-13

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT05874492 2026-04-13

FIBROTHERME

Phase NA Recruiting

BreastHead & Neck

Breast Neoplasms, Fibrosis, Head and Neck Neoplasms

NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT07069595 2026-04-13

PREDICT-RD

Phase 2 Recruiting

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07164976 2026-04-13

Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms

NCT07340541 2026-04-13

EVOLVE-BDT

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07462351 2026-04-13

SPRING

Phase NA Recruiting

Breast Neoplasms

NCT07524114 2026-04-13

SHERLOCK

BreastDermatologicGastrointestinalHead & NeckThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Urogenital Neoplasms, Neoplasm, Residual

NCT04362826 2026-04-09

Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT04841148 2026-04-09

PALAVY

Phase 2 Recruiting

Breast Neoplasms, Neoplasm, Residual

NCT05406232 2026-04-09

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

Breast Neoplasms

NCT06148038 2026-04-09

CBD for Breast Cancer Primary Tumors

Phase 1 Recruiting

Breast Neoplasms

NCT07195344 2026-04-09

TDXdose

Phase 4 Recruiting

Breast Neoplasms

NCT07198724 2026-04-09

ERADICATE

Phase 1/2 Recruiting

Breast Neoplasms

NCT07220967 2026-04-09

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

Phase 4 Recruiting

Breast Neoplasms

NCT07227233 2026-04-09

AIM-BRIGHT

Phase 2 Recruiting

Breast Neoplasms

NCT07520760 2026-04-09

MBC-EA

Phase 2 Recruiting

Breast Neoplasms

NCT04886531 2026-04-08

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Phase 2 Recruiting

Breast Neoplasms

NCT05334732 2026-04-08

SIS

Phase NA Recruiting

Breast Neoplasms

NCT05535192 2026-04-08

THRIVE-65

Phase NA Recruiting

Breast Neoplasms

NCT05825482 2026-04-08

Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout®

Phase NA Recruiting

Breast Neoplasms

NCT06649331 2026-04-08

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06758102 2026-04-08

Dance Study for Post-surgical Pain in Breast Cancer Survivors

Phase NA Recruiting

Breast Neoplasms, Pain, Postoperative

NCT06915168 2026-04-08

CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT02819882 2026-04-07

REGISTEM

Breast Neoplasms, Neoplasm Metastasis

NCT03897270 2026-04-07

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Phase NA Recruiting

Breast Neoplasms

NCT05334069 2026-04-07

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

BreastDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06896474 2026-04-07

SDMPOSSIBLE

Phase NA Recruiting

Breast Neoplasms